ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

INCRUSE ELLIPTA
Asthma/COPD
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

INCRUSE ELLIPTA Rx

Generic Name and Formulations:
Umeclidinium 62.5mcg; per inhalation; dry pwd for oral inhalation; contains lactose.

Company:
GlaxoSmithKline

Therapeutic Use:

Indications for INCRUSE ELLIPTA:

Long-term maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema. 

Adult:

Take at same time every day. 1 inhalation every 24hrs.

Children:

Not established.

Contraindications:

Severe hypersensitivity to milk proteins.

Warnings/Precautions:

Not indicated for relief of acute bronchospasm. Do not initiate in rapidly or acutely deteriorating COPD. Do not exceed recommended dose. Reevaluate periodically. Prescribe a short-acting, inhaled β2-agonist for acute symptoms; monitor for increased need. Discontinue if paradoxical bronchospasm (use alternatives) or hypersensitivity reactions occur. Narrow-angle glaucoma. Urinary retention. Prostatic hyperplasia. Bladder-neck obstruction. Severe hepatic impairment. Labor and delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Additive effects with concomitant other anticholinergic-containing drugs; avoid.

Pharmacological Class:

Anticholinergic.

Adverse Reactions:

Nasopharyngitis, URTI, cough, arthralgia; visual disturbances, paradoxical bronchospasm.

How Supplied:

Dry pwd inhaler—30 doses

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs